AT
DXCM icon

Arden Trust’s DexCom DXCM Stock Holding History

Arden Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,725
Closed -$350K – 248
2023
Q2 		$350K Sell
2,725
-2,154
-44% -$261K 0.06% 184
2023
Q1 		$567K Sell
4,879
-148
-3% -$16.6K 0.1% 161
2022
Q4 		$569K Sell
5,027
-73
-1% -$8.02K 0.12% 156
2022
Q3 		$411K Sell
5,100
-76
-1% -$6.44K 0.1% 182
2022
Q2 		$385K Buy
5,176
+684
+15% +$62.4K 0.09% 195
2022
Q1 		$575K Buy
4,492
+808
+22% +$88.4K 0.11% 166
2021
Q4 		$495K Sell
3,684
-64
-2% -$9.2K 0.08% 198
2021
Q3 		$512K Sell
3,748
-448
-11% -$56.5K 0.09% 194
2021
Q2 		$448K Buy
+4,196
New +$403K 0.07% 210
2017
Q2 		– Sell
-11,132
Closed -$236K – 358
2017
Q1 		$236K Buy
+11,132
New +$217K 0.04% 316

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arden Trust's DXCM Position: Q3 2023 in Review

Arden Trust sold out of DexCom (DXCM) in Q3 2023, closing a stake of 2,725 shares — an estimated $350K sold.

Arden Trust first reported a position in DXCM in Q1 2017 and held it in 10 quarters. The position peaked at $575K in Q1 2022. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Arden Trust reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Arden Trust sold 2,725 DexCom shares in Q3 2023, an estimated $350K.
  • Arden Trust first reported a position in DexCom in Q1 2017 and held it in 10 quarters.
  • Arden Trust's DexCom position peaked at $575K in Q1 2022.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Arden Trust's 13F filing for Q3 2023, filed 10 Oct 2023.